Diagnostics startup ecosystem
We track 11 organisations in this sector across 5+ countries.
Showing 11 of 11Diagnostics
Countries in this sector
Sectors alongside this one
Diagnostics results
Aptamedica
Aptamedica is a Warsaw-based medtech startup developing a real-time, point-of-care therapeutic drug monitoring platform for intensive and critical care. Its core product, AptaSense, is a bedside analyzer that uses single-use, aptamer-based (DNA biosensor) test strips to measure blood concentrations of antibiotics such as vancomycin, gentamicin and amikacin, plus the sepsis biomarker procalcitonin, returning results in roughly one minute from a venous sample — removing the need to send samples to a central lab and enabling immediate, precise dosing. The platform extends beyond the handheld analyzer: AptaFlow integrates into haemodialysis circuits for continuous real-time drug monitoring, while AptaSoft is an AI-assisted dosing tool aimed at neonatal care. New analytes such as troponin and digoxin are in the development pipeline and can be added via software. Founded by Maciej Łach, Mateusz Fil and Kamil Pawełkiewicz, the company is at prototype stage and has taken part in Polish innovation programmes including Warsaw Booster and the Mother and Child Startup Challenge; no external funding round has been publicly disclosed to date.
Ena Prosser
Partner and co-founder of Fountain Healthcare Partners. A biotechnologist with a PhD and former Enterprise Ireland and Elan experience, she leads investments across biopharma and diagnostics and manages many of the firm's cross-sector relationships.
Fountain Healthcare Partners
Fountain Healthcare Partners is Ireland's largest dedicated life-sciences venture firm, founded in 2008 as a spin-out from Elan Corporation's investment group. Headquartered in Dublin with an office in New York, it was established by Manus Rogan, Aidan King, Ena Prosser and Justin Lynch, and manages more than €425M across four funds. The firm invests at seed and early stage across specialty pharma, biopharmaceuticals, medical devices and diagnostics — primarily in Europe with selective US positions — typically leading or co-leading syndicates with €0.5–7M initial cheques and active follow-on. Fund III closed at €125M in 2020 with anchor commitments from the European Investment Fund, the Ireland Strategic Investment Fund, AIB and Japan's Kyowa Kirin, and Fund IV is now active. The portfolio has produced landmark exits including Inflazome (acquired by Roche for €380M upfront, 2020), KaNDy Therapeutics (Bayer, $425M upfront, 2020), Syndesi Therapeutics (AbbVie, 2022), Calypso Biotech (Novartis, 2024) and Vivasure Medical (Haemonetics, 2026). Active holdings include the Irish medtechs Neuromod Devices and Neurent Medical, Germany's Exciva and Belgium's Dualyx.
Infermedica
Health AI company building medical guidance and triage tools for providers, insurers, and digital health platforms. Its platform automates symptom assessment and patient routing in multiple languages across international markets.
LetsGetChecked
LetsGetChecked is a Dublin-founded at-home diagnostics and virtual care company that ships regulated lab tests directly to consumers, processes samples through its own CLIA-certified laboratories, and wraps the results in physician review, prescribing, and follow-up care where appropriate. Founded in 2015 by Peter Foley, the company rode the pandemic-era shift toward home testing to a USD 1 billion Series D in 2021 and has since positioned itself as a full virtual-care platform covering sexual health, men's and women's health, wellness, colorectal screening, and medication adherence, selling both direct-to-consumer and as a corporate health benefit. It is one of the few European health-tech unicorns to successfully run end-to-end clinical infrastructure — labs, logistics, telehealth, and pharmacy — in the US market, and together with Kerecis and Sidekick Health it rounds out the directory's picture of how Irish and Icelandic health companies are building internationally regulated care businesses.
MultiplexDX
MultiplexDX focuses on precision cancer diagnostics, developing visualized diagnostic tests aimed at reducing misdiagnosis in oncology. Its work is particularly focused on breast cancer and improving clinical decision confidence. By 2026, the company is a high-impact biotech research player in the Slovak ecosystem with expanding clinical collaborations.
Neko Health
Neko Health is a Stockholm-based preventive health company co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek (the Spotify founder). Neko operates clinics that offer AI-powered full-body health scans using proprietary sensors and imaging technology to detect early signs of cardiovascular disease, skin cancer, diabetes, and other conditions. A scan takes about 15 minutes and costs a fraction of traditional medical imaging. The company has raised over $260 million, including a $260 million round in 2024, and is expanding its clinic network across Sweden and the UK. Neko Health represents a new model of proactive, technology-driven healthcare that could reshape how Europeans approach preventive medicine.
Neulogy Ventures
Neulogy Ventures is one of the leading deeptech venture capital funds in Central and Eastern Europe, established in 2014 and operating from Bratislava with a Luxembourg fund structure. It manages €65 million in assets under management across approximately 30 portfolio companies in 10 countries, writing cheques of €200,000–€3 million primarily at Seed and Series A stages. The fund targets mission-driven Slovak and CEE technology companies addressing climate change, healthcare, and industrial automation. Institutional co-investors include the European Investment Fund, Slovak Investment Holding, and Tatra banka.
Powerful Medical
Powerful Medical builds clinical-grade AI for cardiology. Its flagship product, PMcardio, can diagnose acute heart attacks by analyzing a photo of a 12-lead ECG, outperforming average human interpretation in critical scenarios. The system is FDA and MDR certified and is being rolled out in hospitals across Europe and the UK. By 2026, Powerful Medical is one of the region’s most credible medical AI companies with global regulatory traction.
RobotDreams
RobotDreams is a Graz-based healthtech startup founded in 2022 that develops AI diagnostics software analyzing blood biomarker data to accelerate detection of acute conditions such as acute coronary syndrome. The platform aims to reduce diagnostic turnaround times in emergency departments by applying machine learning to in-vitro diagnostics results, helping clinicians make faster triage decisions. RobotDreams competes in the growing AI-enabled clinical diagnostics space and targets hospitals, laboratories, and emergency-care providers across Europe.
Seroba Life Sciences
Seroba Life Sciences is a Dublin-based healthcare venture capital firm founded in 2002, investing in biotech, medical devices, and diagnostics across Europe with a focus on companies emerging from strong clinical and scientific foundations. The firm manages over EUR 300M and typically invests EUR 2-10M at Series A and B, taking board seats and providing strategic guidance on regulatory strategy and commercialization. Seroba has backed companies including Mainstay Medical, Aerogen, and Fire1, leveraging Ireland's deep life sciences talent pool and its proximity to major pharma and medtech multinationals headquartered in the country.
